Clinical Trials Logo

Clinical Trial Summary

This study will determine the ability of three different intraocular lenses to accommodate in patients who have previously undergone bilateral intraocular lens implantation.


Clinical Trial Description

n/a


Study Design

Observational Model: Case-Only, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


NCT number NCT01004549
Study type Observational
Source Innovative Medical
Contact
Status Completed
Phase N/A
Start date October 2009
Completion date June 2011

See also
  Status Clinical Trial Phase
Recruiting NCT01193504 - Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification Phase 4
Completed NCT00347243 - Wavefront Analisys and Contrast Sensitivity of Spherical and Aspherical Intraocular Lenses Phase 4
Completed NCT04208633 - Correlation Between Sulcus Anatomy and Other Parameters After Horizontal & Vertical Intraocular Lens (IOLs) Placements N/A
Recruiting NCT06041139 - Visual Outcomes and Patient Satisfaction With Bilateral PanOptix Verses Bilateral Synergy
Recruiting NCT04533191 - Binocular Custom Vision Utilizing The Light Adjustable Lens (LAL)
Completed NCT05735990 - Retrospective Clinical Investigation of the Safety and Performance of 640PM Trifocal IOL Implantation in Patients With Cataract and/or Ametropia (Hyperopia, Myopia) and/or Presbyopia
Recruiting NCT04175951 - Tecnis Eyhance Versus Rayner RayOne Study N/A
Not yet recruiting NCT06056154 - Safety and Efficacy of the Hydrophobic Intraocular Lens AsqelioTM Monofocal With Biaspheric Design
Not yet recruiting NCT05531110 - Comparison of Two Aspheric Intraocular Lenses for Micro-monovision N/A
Recruiting NCT03823092 - Polarization Perception in Health and Disease. Testing a New Sight Test
Completed NCT05226884 - Intermediate Vision in Patients With Clareon IOLs Compared to Eyhance IOLs
Completed NCT01310127 - Clinical Outcomes of Bromday (Bromfenac Ophthalmic Solution) 0.09% QD vs. Nevanac (Nepafenac Ophthalmic Suspension) 0.1% Phase 4
Completed NCT05335408 - Evaluation of Visual Function After Bilateral Implantation of EDOF IOLs N/A
Completed NCT05611073 - Maximizing Visual Outcomes With Eyhance IOLs
Completed NCT04319497 - Subjective and Objective Refraction in Pseudophakic Patients N/A
Completed NCT05418153 - Synergy Lens Outcomes Evaluation
Recruiting NCT06065072 - Comparative Study of the Tomey OA-2000, Tomey CASIA2, and the LenStar LS900
Completed NCT02450799 - Corrected VA With Long-Term Follow-Up After AcrySof® Intraocular Lens (IOL) Implantation N/A
Completed NCT00428363 - Effect of Optic Edge Design in a Silicone Intraocular Lens on Posterior Capsule Opacification Phase 4
Completed NCT04468022 - Toric Trifocal IOL Treatment With High Astigmatism and Hyperopia vs SMILE Enhancement After Trifocal IOL Treatment N/A